Taylor & Francis Journals: Welcome 
Contact Us Careers Members of the Group
Taylor & Francis Journals: Welcome 
Search for Books Journals and eBooks
Journal Listings
Alphabetical Listing
Journals by Subject
New Journals
Author Resources
Author Services
Authors' Newsletter
Copyright & Author Rights
Instructions for Authors
Journals Resources
Advertising
Catalogues
Customer Services
Developing World Initiatives
Email Contents Alerting
eUpdates
Online Information
Online Sample Copies
Permissions
Press Releases
Price List
Publish with Us
Reprints
Special Issues
Special Offers
Subscription Information
Related Websites
Arenas
LibSite
Society Publishing
Routledge Books
Taylor & Francis Books
eBooks

Journal Details

Printer Friendly Page
Journal of Biopharmaceutical Statistics

Journal of Biopharmaceutical Statistics


Now Listed with IF of 0.951 ©2009 Thomson Reuters, 2008 Journal Citiation Reports®
Published By: Taylor & Francis
Volume Number: 20
Frequency: 6 issues per year
Print ISSN: 1054-3406
Online ISSN: 1520-5711
 

Aims & Scope

2008 Impact Factor: 0.951
Ranking: 48/92 in Statistics & Probability; 182/216 in Pharmacology & Pharmacy
© 2009 Thomson Reuters, 2008 Journal Citation Reports®

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers:

  • drug, device, and biological research and development
  • drug screening and drug design
  • assessment of pharmacological activity
  • pharmaceutical formulation and scale-up
  • preclinical safety assessment
  • bioavailability, bioequivalence, and pharmacokinetics
  • phase, I, II, and III clinical development
  • premarket approval assessment of clinical safety
  • postmarketing surveillance

Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

top top
Copyright © 2009 Taylor & Francis Group, an informa business   Privacy Policy   Terms and Conditions